Liensinine
CAS : 2586-96-1
Ref. 3D-FL65625
5mg | 136,00 € | ||
10mg | 192,00 € | ||
25mg | 356,00 € | ||
50mg | 542,00 € | ||
100mg | 777,00 € |
Informations sur le produit
- 4-[[(1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]phenol
- 4-[[(1R)-6,7-Dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[[(1R)-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenol
- 4-{[(1R)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-2-{[(1R)-1-(4-hydroxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}phenol
- Phenol, 4-[(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl]-2-[[1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]-, [R-(R*,R*)]-
- Phenol, 4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[[(1R)-1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinyl]oxy]-
Liensinine is a natural compound that has been shown to induce autophagy in an experimental model of oxidative injury. It has been found to inhibit the production of matrix metalloproteinases (MMPs) and cytokines, which are associated with cancer progression. Liensinine has also been shown to be an MMP-9 activity inhibitor and an inducer of autophagy. The molecular docking analysis demonstrated the binding of liensinine with autophagy inducer molecule, suggesting that it can be used as a therapeutic agent for various diseases such as cancer tissues or cellular physiology.
Propriétés chimiques
Question d’ordre technique sur : 3D-FL65625 Liensinine
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages